A detailed history of Schulhoff & CO Inc transactions in Avadel Pharmaceuticals PLC stock. As of the latest transaction made, Schulhoff & CO Inc holds 137,000 shares of AVDL stock, worth $1.53 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
137,000
Previous 137,000 -0.0%
Holding current value
$1.53 Million
Previous $1.93 Million 6.7%
% of portfolio
0.81%
Previous 0.93%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$12.55 - $17.22 $514,550 - $706,020
41,000 Added 42.71%
137,000 $2.31 Million
Q2 2022

Aug 05, 2022

BUY
$1.07 - $6.95 $37,450 - $243,250
35,000 Added 57.38%
96,000 $234,000
Q3 2020

Nov 04, 2020

BUY
$5.02 - $8.98 $306,220 - $547,780
61,000 New
61,000 $307,000

Others Institutions Holding AVDL

About AVADEL PHARMACEUTICALS PLC


  • Ticker AVDL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 60,581,300
  • Market Cap $677M
  • Description
  • Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...
More about AVDL
Track This Portfolio

Track Schulhoff & CO Inc Portfolio

Follow Schulhoff & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schulhoff & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Schulhoff & CO Inc with notifications on news.